Taking aim at digital disruption to pharma the May issue of PME was out this week in both its print and online incarnations.
The issue also featured an exclusive interview with AstraZeneca’s VP of oncology Susan Galbraith who talked about the company’s pipeline prospects – a topic that shortly after the interview was conducted took on added significance.
It was also time to update our Top Pharma List, detailing the industry’s top performing companies.
Elsewhere PME included insights on topics such as patient-relevant outcomes in Germany’s HTA process, key account management and the new collaborative approaches pharma is taking to R&D.
• Read the May 2014 issue of PME online